Own CMC end-to-end for a trispecific TCE program from discovery handoff to IND, including timeline, budget, and quality.
Run competitive CDMO selection across US, European and Chinese vendors, then negotiate and manage the chosen partner.
Author Module 3, build the pre-IND briefing package, and represent CMC in agency meetings.
Shennon Biotechnologies is developing precision immunotherapies for solid tumors using an integrated platform that profiles millions of single-cell interactions in a single experiment. The company values collaboration, ownership and authenticity and is based in San Francisco.
Drive commercial growth by developing multi-year business plans and leading key oncology accounts.
Educate healthcare leaders on cell therapy logistics and resolve access barriers with cross-functional teams.
Serve as a field leader, coaching colleagues and ensuring compliance with all policies and regulations.
Iovance Biotherapeutics is a biotechnology company that develops and delivers tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. As the first company to commercialize TIL therapy, it operates a large-scale U.S. manufacturing facility and promotes a collaborative, patient-focused culture.
Drives CAR-T brand adoption among institution-based oncology customers.
Navigates complex account environments and triages stakeholder needs.
Leverages territory insights to develop and implement account business plans.
Legend Biotech is a global biotechnology company focused on developing cell therapies for life-threatening diseases. Headquartered in New Jersey, they operate in a fast-paced, entrepreneurial environment and collaborate with Johnson & Johnson.
Own integrated program strategy for TIL cell therapy assets across early-to-late-stage clinical development.
Chair cross-functional program teams, manage timelines, and translate strategy into execution.
Partner with senior leadership to advance programs from early studies to global regulatory submissions.
Iovance Biotherapeutics is a global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. The company operates as an end-to-end cell therapy company with fully owned, centralized U.S.-based manufacturing and is committed to a diverse and inclusive work environment.
Develop and execute targeted engagement strategies for key accounts and treatment centers in the Central US region.
Lead regional business planning and collaborate with cross-functional teams to drive commercial launch readiness.
Serve as primary point of contact for stakeholders, ensuring alignment with corporate goals and market access strategies.
Since 2009, REGENXBIO has pioneered gene therapy, advancing a pipeline of treatments for rare and retinal diseases. Their growing, mission-driven team collaborates to develop transformative therapies for patients in need.
Own revenue generation for Synapticure's Research business lines, focusing on Clinical Research and Real-World Evidence offerings for pharma and biotech partners.
Lead the full deal cycle from sourcing and shaping to closing research engagements, while building relationships with foundations and CROs.
Contribute to product strategy by translating market needs into service definitions, pricing models, and go-to-market positioning.
Synapticure is a specialty care and life sciences company focused on neurodegenerative diseases, providing virtual clinical care and research partnerships. The company is remote-first and mission-driven, founded by patients and caregivers, with a focus on transforming care for conditions like Alzheimer's, Parkinson's, and ALS.
Own commercial growth for biotech and small-to-mid-sized pharma, including revenue, strategy, and pipeline.
Personally close first deals with founders and executives while building and leading a high-performing sales team.
Define go-to-market strategy, prioritize high-value use cases, and partner with Customer Success for expansion.
Hippocratic AI builds the leading frontier model for healthcare, powering safe, autonomous clinical conversations with patients and HCPs. It is one of the fastest-growing health-tech companies, backed by top investors with $404M in funding and a team of experts from leading institutions.
Provide expert regulatory guidance to pharmaceutical and biotech C-suite executives, shaping critical development and portfolio decisions.
Generate new business and meet sales targets while leading complex regulatory engagements and mentoring team members.
Represent Lumanity at industry forums and contribute to practice innovation and thought leadership.
Lumanity is a global strategic partner dedicated to improving health outcomes by accelerating and optimizing access to life-changing medicines. The company brings together strategy, evidence, engagement, and technology to engineer breakthrough value for biopharma clients.
Lead EMEA commercial strategy for clinical NGS, driving revenue, profitability, and market share growth.
Build and mentor a high-performing sales organization across a geographically distributed team.
Manage key customer relationships, distribution partners, and pricing and forecasting excellence.
The hiring company is an organization in the healthcare and life sciences sector, specializing in clinical next-generation sequencing and molecular diagnostics. It operates in a global, matrixed environment that values collaboration, innovation, and remote-first work.
Lead strategic engagement with payers, PBMs, and GPO accounts to secure patient access.
Develop market access strategies and negotiate contracts, including value-based models.
Build and oversee payer account teams while collaborating across functions.
REGENXBIO is a gene therapy company pioneering treatments for rare and retinal diseases. The company fosters a collaborative, patient-focused culture with a talented team working to make a meaningful difference for patients and their families.
Drive commercial growth and technical adoption of Isolere and Purexa purification solutions across the bioprocessing market.
Develop and execute business deals, partnerships, and supply agreements to expand customer base and revenue.
Lead customer engagement, sales forecasting, and commercial team buildout to strengthen market presence.
Donaldson solves complex filtration and contamination control challenges as a global provider of filtration technologies and high-quality filters. With 14,000 employees across 140 locations on six continents, the company fosters a culture of collaboration, innovation, and meaningful contribution.
Own the complete Business Development lifecycle from strategy to negotiation and long-term account management.
Serve as relationship and commercial owner for Business Intelligence, social-listening, and enterprise customer relationships.
Partner cross-functionally to execute strategy across platform initiatives like search, commerce, and data licensing.
Reddit is a community of communities built on shared interests, passion, and trust. With 100,000+ active communities and approximately 130 million daily active unique visitors, it is one of the internet's largest sources of information.
Lead program-level and portfolio-level planning and execution of CMC development for multiple small-molecule assets.
Own detailed CMC project plans and risk registers, partnering with internal and external teams for on-time, within-budget delivery.
Serve as primary point of contact for external CDMOs across China, EU, and US, overseeing manufacturing and documentation timelines.
Enveda is a clinical-stage, AI-enabled biotech company discovering medicines four times faster than the industry standard. The company recently raised $311M in Series E funding and has been recognized as one of America's Best Startup Employers and a Top 100 Most Loved Workplace.
Own drug substance technology transfer, MSAT, and manufacturing oversight for CDMO partners.
Lead process validation, commercialization, and lifecycle management for peptide DS manufacturing.
Build and develop high-performing teams while ensuring cGMP compliance and regulatory readiness.
Kailera Therapeutics is a biopharmaceutical company developing novel therapies for obesity and related conditions. The company fosters an entrepreneurial, team-oriented culture focused on collaboration, integrity, and excellence and is expanding its team.
Lead launch planning and execution across a large U.S. geography to achieve sales and market share goals.
Recruit, onboard, and develop Regional Sales Directors, with indirect oversight of 50–100+ field representatives.
Partner cross-functionally with Market Access, Marketing, and Medical Affairs to support launch readiness.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company developing medicines to treat hypertension and related diseases driven by dysregulated aldosterone. Headquartered in Radnor, Pennsylvania, it is a fully remote company preparing for its first product launch.
Own CMC strategy and execution across the full portfolio, spanning drug substance, drug product, device/combination products, and oral solid dose formulations.
Lead process development, scale-up, technology transfer, and regulatory submissions for CMC and device sections to support global filings.
Build and mentor a high-performing CMC and device engineering organization while partnering cross-functionally with Regulatory, Quality, Clinical, and Commercial teams.
Kailera Therapeutics is a late clinical-stage biotechnology company advancing a pipeline of GLP-1-based therapies for obesity and related conditions, including injectable and oral candidates in global trials. The company fosters an entrepreneurial, team-oriented culture focused on collaboration, integrity, and excellence as it scales toward commercial launch.
Serve as a TIL cell therapy expert in Medical Affairs, educating providers and optimizing tumor tissue procurement.
Lead engagement with surgeons and cross-functional teams to support clinical trials and medical strategy.
Represent Iovance at professional meetings and contribute to publications and educational materials.
Iovance Biotherapeutics is a global leader in developing tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. It is an end-to-end cell therapy company with U.S.-based manufacturing and an inclusive culture.
Own business development end to end, from sourcing and pitching to closing and the initial onboarding of each engagement.
Serve as the CEO's thought partner and number-two operator, building systems and processes for a repeatable pipeline.
Manage senior client relationships and act as connective tissue between clients and delivery teams during kickoff.
NewWorld Inc. is a strategy and communications firm that builds and delivers command centers and client shows. The company operates with a fast-moving, collaborative culture where business development and delivery are tightly connected.
Build and lead the DACH commercial field team, from pre-launch education to key account management.
Own launch plans for ADH1 and achondroplasia, including local marketing and forecasting.
Partner with Medical Affairs, Market Access, and Patient Advocacy for coordinated launch execution.
BridgeBio Pharma is a biotech that uses a 'moneyball' model to fund early-stage research and develop medicines for rare diseases and genetically driven cancers. It values curiosity, experimentation, and a hands-on culture, rewarding high performers.
Lead and develop the West Region Oncology Sales team, driving launch excellence for a personalized mRNA cancer therapy.
Build and execute regional account strategies across complex health systems and oncology practices to achieve sales targets.
Foster a high-performance culture through coaching, compliance, and data-driven decision-making.
Moderna is a biotechnology company pioneering messenger RNA medicines and advancing personalized cancer therapies. It is a high-growth, transformational organization recognized for a bold, relentless, curious, and collaborative culture.